EBC is a network of key players in the “Brain Area”, with a membership encompassing scientific societies, patient organisations, professional societies and industry partners.
5 03-2021

Pioneers in migraine research that has led to the development of new treatments awarded world’s top Brain Prize

2021-03-05T16:37:13+00:0005-03-2021|News|

EBC is pleased to share the announcement of the winners of the 2021 Brain Prize, Professors Lars Edvinsson, Peter Goadsby, Michael Moskowitz, and Jes Olesen, who is the Founding President of EBC. We congratulate them all on their achievement!   A group of four neuroscientists from Denmark, Sweden, UK, and USA who discovered a [...]

3 03-2021

EBC, EFNA and GAMIAN-Europe launch registration for Brain Awareness Week event

2021-03-12T15:48:15+00:0003-03-2021|News|

Brain Awareness Week 2021 EBC in partnership with EFNA & GAMIAN-Europe Patient Engagement in EU-Funded Brain Research Projects Digital Event – 16 March, 12:30-14:00 The European Brain Council (EBC), the European Federation of Neurological Associations (EFNA) and GAMIAN-Europe are pleased to invite you to our upcoming Brain Awareness Week event on Patient Engagement in EU-Funded Brain Research [...]

28 02-2021

EBC raises awareness on Rare Disease Day

2021-02-26T11:31:14+00:0028-02-2021|News|

EBC is happy to recognise and support Rare Disease Day  today, held this year under the theme “Equity”.  As emphasized by EURORDIS, equity in practice means meeting people’s specific needs and eliminating barriers preventing their full participation in society. For people living with a rare disease, equity implies social opportunity, non-discrimination in education and [...]

24 02-2021

What can we learn from the vaccination campaign?

2021-02-24T11:37:34+00:0024-02-2021|News|

Just over a month ago, EBC published its statement on the impact of COVID-19 on brain health, hoping that the growing evidence of the long-term effects of the disease would be taken into account in the planning for post-pandemic recovery at the EU and national levels. It continues to grow more evident that COVID-19 has [...]

18 02-2021

MULTI-ACT project launches Save the Date for Final Conference

2021-02-23T12:30:23+00:0018-02-2021|News|

MULTI-ACT Final Conference The MULTI-ACT Model: The Path Forward for Participatory Governance in Health Research and Innovation 23 March 2021 (14:00-17:00 CET) After years of work, the outcomes of the MULTI-ACT project will be presented at the Final Conference, “The MULTI-ACT model: the path forward for participatory governance in health research and innovation”, to be held [...]

28 01-2021

Event report: Virtual workshop on the off-label use of medicines in Sweden and Norway

2021-02-18T13:43:47+00:0028-01-2021|News|

Striking the right balance between timely access to medicines and maintaining the highest standards of patient safety. Introduction to the event The event, hosted by the Swedish Brain Foundation, the Norwegian MS Association and the European Brain Council was held virtually on 24 November 2020. It brought together over 80 representatives from Norway and [...]

28 01-2021

EU-Funded BRAINTEASER project, bringing AI home for better care of ALS and MS, kicks off!

2022-04-14T12:42:44+00:0028-01-2021|News|

Officially started on the 1st of January 2021, the H2020 BRAINTEASER project kicked off its operational activities on 28 and 29 January, at the presence of its project officer Mr Tobias Wiesenthal, Head of Sector 'Research and Innovation' at DG CONNECT.H.3 – eHealth, Well-Being and Ageing. All the 11 partners, a multidisciplinary gender-balanced consortium [...]

Go to Top